Source disclosure: February 13, 2026
Perseus Proteomics Inc. [4882.T]
TOKYO, Feb 13 (Pulse News Wire) – Perseus Proteomics Inc. (4882.T) reported unusual items for its fiscal third quarter ending March 2026, including non-operating income, expenses, and extraordinary losses.
Non-operating income included grants of ¥53.3 million, foreign exchange gains of ¥8.8 million, and interest income of ¥3.4 million. Operating expenses featured stock issuance costs totaling ¥1.7 million.
Additionally, impairment losses on fixed assets amounted to ¥37,006 thousand, recognized as extraordinary losses based on accounting standards for asset impairments. These figures reflect adjustments made to the company's performance metrics for the quarter, which are detailed in the concurrently released interim earnings report for the same period.
AI-translated content. 🟢 Confidence: High See terms • Original filing